Adjunctive Use of Biologics in Alveolar Ridge Preservation: A Narrative Review

Background: The purpose of alveolar ridge preservation (ARP) is to minimise the physiological alveolar ridge reduction occurring after dental extraction, which can prevent the need for future alveolar ridge augmentation. Biologic materials (biologics) promote tissue regeneration based on their effect on wound healing at a cellular level. By integrating biologics into ARP biomaterials, there is a potential to enhance the regeneration of both hard and soft tissues with greater efficacy. Aim: This narrative review aims to evaluate the clinical efficacy of the addition of biologics to existing ARP materials on the physiological changes following ARP of an extraction site. Methods: A search of the PubMed electronic database was conducted, and relevant articles were examined. Sixty-three articles met the inclusion and exclusion criteria and were included in this review. Results and Conclusions: A review of the existing literature found that the combination of biologics with ARP materials resulted in similar dimensional changes when compared to using ARP materials alone. Existing research has identified an enhancement in bone density, increased wound healing capacity of soft and hard tissue, and a reduction in post-operative pain. Whilst the addition of biologics to ARP materials has shown an increase in bone density, its effectiveness in improving implant outcomes and reducing the need for future alveolar ridge augmentation is unclear. Recognising the limitations within the existing literature, along with the risk of bias and heterogeneity, renders it unwise to make definite conclusions about the benefits of integrating biologics with ARP materials. This narrative review found possible benefits in the use of biologics in ARP to optimise patient-related and treatment outcomes, indicating the need for additional research.